Clarke Futch (Healthcare Royalty)
July 29, 2021 05:28 PM EDT
Financing

Roy­al­ty Phar­ma com­peti­tor stirs the pot with plans for $750M IPO

Max Gelman

Senior Editor

Os­ten­si­bly aim­ing to pig­gy­back off the suc­cess of Roy­al­ty Phar­ma and CEO Pablo Legor­re­ta’s IPO in June 2020, an­oth­er roy­al­ty-gob­bling com­pa­ny is near­ly set to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times